Evidence map›Paper›PMID 39312471›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2024

Spatial Isoforms Reveal the Mechanisms of Metastasis.

Yin Yin, Yuhao Wang, Xiao Yu, Yang Li, Yahui Zhao, Yanfeng Wang, Zhihua Liu

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Spatial Isoforms Reveal the Mechanisms of Metastasis.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yin YinState Key Laboratory of Molecular Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.ORCID 0000-0002-9934-1838
Yuhao WangState Key Laboratory of Molecular Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Xiao YuState Key Laboratory of Molecular Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Yang LiState Key Laboratory of Molecular Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Yahui ZhaoState Key Laboratory of Molecular Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Yanfeng WangDepartment of Comprehensive Oncology, National Cancer Center/National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Zhihua LiuState Key Laboratory of Molecular Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.ORCID 0000-0003-4242-033X

Funding

Beijing Nova Program 20230484383CAMS Innovation Fund for Medical Sciences 2021-I2M-1-018CAMS Innovation Fund for Medical Sciences 2022-I2M-1-009CAMS Innovation Fund for Medical Sciences 2022-I2M-2-001Fundamental Research Funds for the Central Universities 3332021091National Key R&D Program of China 2020YFA0803300National Key R&D Program of China 2021YFC2501000National Key R&D Program of China 2021YFC2501900National Natural Science Foundation of China 82030089National Natural Science Foundation of China 82188102National Natural Science Foundation of China 82273453Shenzhen Medical Research Funds C2303002Young Elite Scientists Sponsorship Program by CAST 2023QNRC001
6 · The paper itself

Abstract

In esophageal squamous cell carcinoma (ESCC), lymph node (LN) metastasis is associated with poor survival. Emerging evidence has demonstrated elevated CD8

Indexed as

Esophageal NeoplasmsCD8-Positive T-LymphocytesEsophageal Squamous Cell CarcinomaHumansLymphatic MetastasisProtein IsoformsProtein IsoformsCD74chemoresistantesophageal squamous cell carcinomaexhausted T cellsmetastasisspatial isoformstumor‐associated macrophage

Identifiers

PMID39312471
PMCPMC11578385

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.